May 18, 2022 — XACT Robotics, developer of the world’s first and only comprehensive robotic system for interventional radiology, announced today that the XACT

May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours during the weekday, followed by 16 hours of fasting, lowered their risk of cardiovascular disease (CVD) after a few weeks, according to a new research letter publishing in JACC: CardioOncolog

May 18, 2022 — Continuous monitoring with an insertable cardiac monitor (ICM) is shown to be more successful in detecting atrial fibrillation (AF) than conventional intermittent monitoring in patients with strokes attributed to large artery athero

May 18, 2022 — For the third straight year, Henry Ford Hospital interventional cardiologist Khaldoon Alaswad, M.D. will perform a  live heart procedure as part of an international interactive medical education event, with proceeds benefiting hospitals in Ukraine.

May 17, 2022 — Results of a new study reveal Black patients hospitalized with atrial fibrillation (AF) are under-prescribed blood thinners that can reduce the risk of stroke. Further, the findings indicate Black patients experience higher rates of AF-related outcomes like stroke one-year after discharge compared to white patients.

May 17, 2022 — Results from a new study show success of intended same day discharge (SDD) improves over time for patients undergoing atrial fibrillation (AF) ablation. The new care strategy was overseen by allied health professionals (AHPs) and included integrated telehealth monitoring. Findings were presented as part of Heart Rhythm 2022 on Sunday, May 1.

May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding this year's conference. More than 7,700+ heart rhythm professionals from around the world whose participation during Heart Rhythm 2022, along with their shared ideas and expertise, helped make this year's annual meeting a success.

Here is a look at the conference by the numbers:

May 17, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost-effectiveness of VASCEPA (icosapent ethyl), presented in two poster presentations at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions in Reston, VA, May 13-14, 2022, showcase

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now